Cargando…

Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy

Accumulating evidence suggests that certain features of hepatitis C virus (HCV), especially its high genetic variability, might be responsible for the low efficiency of anti-HCV treatment. Here, we present a bioinformatic analysis of HCV-1a populations isolated from 23 children with chronic hepatiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Figlerowicz, Magdalena, Jackowiak, Paulina, Formanowicz, Piotr, Kędziora, Paweł, Alejska, Magdalena, Malinowska, Nelli, Błażewicz, Jacek, Figlerowicz, Marek
Formato: Texto
Lenguaje:English
Publicado: Springer Vienna 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2982956/
https://www.ncbi.nlm.nih.gov/pubmed/20842394
http://dx.doi.org/10.1007/s00705-010-0789-7
_version_ 1782191775268470784
author Figlerowicz, Magdalena
Jackowiak, Paulina
Formanowicz, Piotr
Kędziora, Paweł
Alejska, Magdalena
Malinowska, Nelli
Błażewicz, Jacek
Figlerowicz, Marek
author_facet Figlerowicz, Magdalena
Jackowiak, Paulina
Formanowicz, Piotr
Kędziora, Paweł
Alejska, Magdalena
Malinowska, Nelli
Błażewicz, Jacek
Figlerowicz, Marek
author_sort Figlerowicz, Magdalena
collection PubMed
description Accumulating evidence suggests that certain features of hepatitis C virus (HCV), especially its high genetic variability, might be responsible for the low efficiency of anti-HCV treatment. Here, we present a bioinformatic analysis of HCV-1a populations isolated from 23 children with chronic hepatitis C (CHC) subjected to interferon–ribavirin therapy. The structures of the viral quasispecies were established based on a 132-amino-acid sequence derived from E1/E2 protein, including hypervariable region 1 (HVR1). Two types of HCV populations were identified. The first type, found in non-responders, contained a small number of closely related variants. The second type, characteristic for sustained responders, was composed of a large number of distantly associated equal-rank variants. Comparison of 445 HVR1 sequences showed that a significant number of variants present in non-responding patients are closely related, suggesting that certain, still unidentified properties of the pathogen may be key factors determining the result of CHC treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00705-010-0789-7) contains supplementary material, which is available to authorized users.
format Text
id pubmed-2982956
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-29829562010-12-15 Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy Figlerowicz, Magdalena Jackowiak, Paulina Formanowicz, Piotr Kędziora, Paweł Alejska, Magdalena Malinowska, Nelli Błażewicz, Jacek Figlerowicz, Marek Arch Virol Original Article Accumulating evidence suggests that certain features of hepatitis C virus (HCV), especially its high genetic variability, might be responsible for the low efficiency of anti-HCV treatment. Here, we present a bioinformatic analysis of HCV-1a populations isolated from 23 children with chronic hepatitis C (CHC) subjected to interferon–ribavirin therapy. The structures of the viral quasispecies were established based on a 132-amino-acid sequence derived from E1/E2 protein, including hypervariable region 1 (HVR1). Two types of HCV populations were identified. The first type, found in non-responders, contained a small number of closely related variants. The second type, characteristic for sustained responders, was composed of a large number of distantly associated equal-rank variants. Comparison of 445 HVR1 sequences showed that a significant number of variants present in non-responding patients are closely related, suggesting that certain, still unidentified properties of the pathogen may be key factors determining the result of CHC treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00705-010-0789-7) contains supplementary material, which is available to authorized users. Springer Vienna 2010-09-15 2010 /pmc/articles/PMC2982956/ /pubmed/20842394 http://dx.doi.org/10.1007/s00705-010-0789-7 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Article
Figlerowicz, Magdalena
Jackowiak, Paulina
Formanowicz, Piotr
Kędziora, Paweł
Alejska, Magdalena
Malinowska, Nelli
Błażewicz, Jacek
Figlerowicz, Marek
Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy
title Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy
title_full Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy
title_fullStr Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy
title_full_unstemmed Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy
title_short Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy
title_sort hepatitis c virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2982956/
https://www.ncbi.nlm.nih.gov/pubmed/20842394
http://dx.doi.org/10.1007/s00705-010-0789-7
work_keys_str_mv AT figlerowiczmagdalena hepatitiscvirusquasispeciesinchronicallyinfectedchildrensubjectedtointerferonribavirintherapy
AT jackowiakpaulina hepatitiscvirusquasispeciesinchronicallyinfectedchildrensubjectedtointerferonribavirintherapy
AT formanowiczpiotr hepatitiscvirusquasispeciesinchronicallyinfectedchildrensubjectedtointerferonribavirintherapy
AT kedziorapaweł hepatitiscvirusquasispeciesinchronicallyinfectedchildrensubjectedtointerferonribavirintherapy
AT alejskamagdalena hepatitiscvirusquasispeciesinchronicallyinfectedchildrensubjectedtointerferonribavirintherapy
AT malinowskanelli hepatitiscvirusquasispeciesinchronicallyinfectedchildrensubjectedtointerferonribavirintherapy
AT błazewiczjacek hepatitiscvirusquasispeciesinchronicallyinfectedchildrensubjectedtointerferonribavirintherapy
AT figlerowiczmarek hepatitiscvirusquasispeciesinchronicallyinfectedchildrensubjectedtointerferonribavirintherapy